Overview

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This is a randomized, half-face study. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide or dapsone gel and the contra lateral side of the face will remain non-treated to serve as a control.
Phase:
Phase 4
Details
Lead Sponsor:
Stiefel, a GSK Company
Collaborator:
GlaxoSmithKline
Treatments:
Benzoyl Peroxide
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Dapsone